Thakur et al. investigated whether ATC armed with bispecific antibodies (aATCs) could inhibit tumor growth and in turn decrease MDSC levels in a microenvironment enriched with IL-2 and INF gamma cytokines. The gene discussed is IL2; the disease is neoplasm.